Summary This study looked at the performance of the heart as they followed 31 patients, each undergoing a course of 60 hyperabric sessions with the goal of improving cognitive performance. Of these 31 patients, 39% were diagnosed with heart disease, [..]
Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder
Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment for many neurological and mood disorders, and the cutting-edge medical technology recently reached another major milestone that should accelerate demand for the non-drug treatment option.
The US Food and Drug Administration (FDA) announced in August that it had approved TMS to be marketed as a treatment for obsessive compulsive disorder (OCD). The FDA previously permitted marketing TMS as a treatment for major depression in 2008 and expanded the use to include TMS for treating pain associated with certain migraine headaches in 2013.
“This is another exciting moment for everyone involved in TMS therapy, and provides additional validation for the effectiveness of TMS,” said Mark Heatwole, President of TheraMind Services, Inc. “This is an important step in the positive momentum toward making TMS a universally available treatment for those suffering from neurological and other mood disorders.”
Click here to read the full news release from the FDA.
To learn more about TMS therapy and other treatments offered at the TheraMind Center of Santa Barbara, call (805) 845-4455 or visit tmsmind.com/santabarbara-ca.
About the TheraMind Center of Santa Barbara
The TheraMind Center of Santa Barbara is committed to improving the lives of patients by providing physicians with the most advanced therapeutic, non-drug alternatives for treating a broad variety of neurological and behavioral disorders. Our doctors successfully treat patients suffering from treatment-resistant depression (TRD), Major Depressive Disorder (MDD), Anxiety Disorder, Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, Obsessive Compulsive Disorder (OCD) and other mood disorders. The Center also routinely treats patients suffering from a variety of neurological disorders including Chronic Pain, Fibromyalgia, Migraines, Tinnitus, Stroke-related disorders, Concussion and TBI, and others.
We employ advanced diagnostic technologies such as fMRI and genetic testing to assist our physicians and referring medical professionals in assessing patient needs. Our highly-trained staff members are committed to providing outstanding supporting services to referring medical professionals, their patients and the patients’ family members.